Abstract
Aminopeptidase N (APN) is a ubiquitous enzyme overexpressed on tumor cells and plays an important role in angiogenesis and metastasis of tumor. Bestatin as an effective inhibitor of aminopeptidase N is used for complementary treatment of cancer with other drugs. In this work, we reformed the structure of bestatin to a new derivative LYP3 to improve the water solubility and effectiveness. The inhibitory activity of LYP3 against APN was evaluated in vitro.
Keywords: Aminopeptidase N, bestatin, tumorigenesis, A549, ES-2, MDA-MB-231, tumor cells, angiogenesis, metastasis of tumor, met-alloprotease, angiotensin, enkephalin, neovascularization, leukemia, pharmacokinetics, biotransformation, L-serine benzylamine, flash chromatography, acylation, recrystallization, Water Solubility Assay, Lambert-Beer law, APN Inhibition Assay, L-leucine-p-nitroanilide, microsomal amino-peptidase, MMP-2 Inhibition Assay, ma-trix metalloproteinase-2 (MMP-2), MTT Assay, fetal bovine serum, diphenyltetrazolium bromide, mono-hydrochloride salt, APN high-expressed tumor cell line, APN low-expressed tumor cell line, immunostimulating effect
Medicinal Chemistry
Title: LYP3, a New Bestatin Derivative for Aminopeptidase N Inhibition
Volume: 7 Issue: 1
Author(s): Yepeng Luan, Chunhua Ma, Zhongguo Sui, Xuejian Wang, Jinhong Feng, Ning Liu, Fanbo Jing, Yan Wang, Minyong Li, Hao Fang and Wenfang Xu
Affiliation:
Keywords: Aminopeptidase N, bestatin, tumorigenesis, A549, ES-2, MDA-MB-231, tumor cells, angiogenesis, metastasis of tumor, met-alloprotease, angiotensin, enkephalin, neovascularization, leukemia, pharmacokinetics, biotransformation, L-serine benzylamine, flash chromatography, acylation, recrystallization, Water Solubility Assay, Lambert-Beer law, APN Inhibition Assay, L-leucine-p-nitroanilide, microsomal amino-peptidase, MMP-2 Inhibition Assay, ma-trix metalloproteinase-2 (MMP-2), MTT Assay, fetal bovine serum, diphenyltetrazolium bromide, mono-hydrochloride salt, APN high-expressed tumor cell line, APN low-expressed tumor cell line, immunostimulating effect
Abstract: Aminopeptidase N (APN) is a ubiquitous enzyme overexpressed on tumor cells and plays an important role in angiogenesis and metastasis of tumor. Bestatin as an effective inhibitor of aminopeptidase N is used for complementary treatment of cancer with other drugs. In this work, we reformed the structure of bestatin to a new derivative LYP3 to improve the water solubility and effectiveness. The inhibitory activity of LYP3 against APN was evaluated in vitro.
Export Options
About this article
Cite this article as:
Luan Yepeng, Ma Chunhua, Sui Zhongguo, Wang Xuejian, Feng Jinhong, Liu Ning, Jing Fanbo, Wang Yan, Li Minyong, Fang Hao and Xu Wenfang, LYP3, a New Bestatin Derivative for Aminopeptidase N Inhibition, Medicinal Chemistry 2011; 7 (1) . https://dx.doi.org/10.2174/157340611794072706
DOI https://dx.doi.org/10.2174/157340611794072706 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
Call for Papers in Thematic Issues
Carbohydrates in Computational and Medicinal Chemistry
Carbohydrates are the most essential organic molecules and are involved in the maintenance of various physiological and metabolic processes in living organisms. Carbohydrate-based compounds have come to the attention of researchers because of their significant contributions to biological functions, such as cell development and cell proliferation, connections between several cells, ...read more
Recent Advances in the Medicinal Chemistry of Cancer
Scope of the Thematic Issue: Correlation between structure and function is one of the important aspects of the success of anti-cancer compounds associated with their structure-activity interactions, physiology, biochemical, molecular, and genetic processes. Overcoming these obstacles is key to obtaining further insights into developments in rational drug design, bioorganic chemistry, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Islet Purification for Clinical Islet Transplantation
Current Tissue Engineering (Discontinued) Smart Polymer Based Delivery Systems for Peptides and Proteins
Recent Patents on Drug Delivery & Formulation Is there U-turn from Insulin Back to Pills in Diabetes?
Current Vascular Pharmacology Nutrient Regulation of Tumor and Vascular Endothelial Cell Proliferation
Current Cancer Drug Targets TNFα Modulation of Visceral and Spinal Sensory Processing
Current Pharmaceutical Design Editorial (Thematic Issue: Controversies in Ocular Pharmacology)
Current Pharmaceutical Design Should the Status of the Pathway Mediated by BRCA1 and BRCA2 be Evaluated Before Selecting Cancer Chemotherapy Drugs?
Current Pharmacogenomics A Comparison of the Inhibitory Effects of Anti-Cancer Drugs on Thioredoxin Reductase and Glutathione S-Transferase in Rat Liver
Anti-Cancer Agents in Medicinal Chemistry Immune Checkpoint Inhibitors: Recent Clinical Advances and Future Prospects
Current Medicinal Chemistry Current Advances in Retroviral Gene Therapy
Current Gene Therapy Probiotics as Anti-Helicobacter pylori Agent: State of the Art
Anti-Infective Agents The Acute Phase Protein α1-Acid Glycoprotein: A Model for Altered Glycosylation During Diseases
Current Protein & Peptide Science Drugs that Target Lipoxygenases and Leukotrienes as Emerging Therapies for Asthma and Cancer
Current Drug Targets - Inflammation & Allergy HIV-1 TAT and IMMUNE DYSREGULATION in AIDS PATHOGENESIS: a THERAPEUTIC TARGET
Current Drug Targets Synergy Against Fungal Pathogens: Working Together is Better Than Working Alone
Current Medicinal Chemistry Osteoprotegerin and Diabetes-Associated Pathologies
Current Molecular Medicine Cardiac Oxidative Stress and Inflammation are Similar in SAMP8 and SAMR1 Mice and Unaltered by Curcumin and Ginkgo biloba Extract Intake
Current Pharmaceutical Biotechnology Blocking Receptor Protein Tyrosine Phosphatase β /ζ: A Potential Therapeutic Strategy for Parkinsons Disease
Current Medicinal Chemistry Progestins for Symptomatic Endometriosis: Results of Clinical Studies
Current Drug Therapy Renin Angiotensin System and Cytokines in Chronic Kidney Disease: Clinical and Experimental Evidence
Protein & Peptide Letters